Skip to main content
SupplementScience

Palmitoylethanolamide (PEA) Side Effects & Safety

This content is for informational purposes only and does not constitute medical advice. Consult your healthcare provider before starting any supplement. Full disclaimer

Safety Profile

Overall safety rating: Generally Safe

Potential Side Effects

  • Very well tolerated — no significant side effects reported in clinical trials at doses up to 1,200mg/day
  • Rare mild GI discomfort
  • No psychoactive effects despite endocannabinoid system modulation
  • No withdrawal effects or tolerance development reported

Drug & Supplement Interactions

  • No known drug interactions — PEA is an endogenous compound with a very clean safety profile
  • May complement analgesics (NSAIDs, acetaminophen, pregabalin) — additive pain relief without adverse interactions
  • Theoretically safe to combine with most medications, but inform your healthcare provider

Maximum Dose

Do not exceed: Up to 1,200mg/day has been used in clinical trials; no dose-limiting toxicity has been identified

References

  1. (). Palmitoylethanolamide, a special food for medical purposes, in the treatment of chronic pain: a pooled data meta-analysis. Pain Physician.
  2. (). Therapeutic utility of palmitoylethanolamide in the treatment of neuropathic pain associated with various pathological conditions: a case series. Journal of Pain Research. DOI
  3. (). The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations. British Journal of Pharmacology. DOI